<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03505047</url>
  </required_header>
  <id_info>
    <org_study_id>007/2018</org_study_id>
    <nct_id>NCT03505047</nct_id>
  </id_info>
  <brief_title>Immediate Versus Delayed IUD Insertion After Second Trimester Medical Abortion</brief_title>
  <official_title>Immediate Versus Delayed Insertion of the Copper IUD After Second-trimester Medical Abortion - a Randomised Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cape Town</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Cape Town</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of the study is to compare use, in a randomised controlled trial, of the
      the copper IUD if inserted immediately after completion of a second trimester medical
      abortion, to standard care with insertion 3-4 or more weeks after abortion at community
      health centres.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 10, 2018</start_date>
  <completion_date type="Actual">January 31, 2020</completion_date>
  <primary_completion_date type="Actual">August 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Use of the copper IUD</measure>
    <time_frame>6 weeks after second trimester abortion</time_frame>
    <description>Number of women using the IUD</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Insertion of the IUD</measure>
    <time_frame>6 weeks after second trimester abortion</time_frame>
    <description>Number of IUD insertions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Use of the IUD at 3 months post-abortion</measure>
    <time_frame>3 months after second trimester medical abortion</time_frame>
    <description>Number of women using the IUD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of the IUD at 6 months post-abortion</measure>
    <time_frame>6 months after second trimester medical abortion</time_frame>
    <description>Number of women using the IUD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spontaneous expulsion of the IUD</measure>
    <time_frame>6 weeks post-abortion</time_frame>
    <description>Number of full and partial expulsions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spontaneous expulsion of the IUD</measure>
    <time_frame>Between 6 weeks and 3 months post abortion</time_frame>
    <description>Number of full and partial expulsions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spontaneous expulsion of the IUD</measure>
    <time_frame>Between 3 and 6 months post abortion</time_frame>
    <description>Number of full and partial expulsions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Removal of IUD and associated factors</measure>
    <time_frame>within 3 and 6 months post-abortion</time_frame>
    <description>Number of removals</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abortion-related and IUD-related complications</measure>
    <time_frame>within 3 months post-abortion</time_frame>
    <description>Number of complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Women's satisfaction and acceptability of the IUD</measure>
    <time_frame>Reported at 3 and 6 months post-abortion</time_frame>
    <description>5 point scales</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrent pregnancy</measure>
    <time_frame>At 6 months post-abortion</time_frame>
    <description>Number of recurrent pregnancies</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Contraception</condition>
  <arm_group>
    <arm_group_label>Immediate group:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Copper Intrauterine device will be inserted within 24 hours of the expulsion of the fetus and placenta or after surgical evacuation for placental remains, and prior to discharge from the facility.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delayed Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The Copper Intrauterine device will be inserted at a local community health centre 14-28 days after discharge.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Copper Intrauterine device</intervention_name>
    <description>Immediate insertion of the copper intrauterine device after completion of abortion</description>
    <arm_group_label>Immediate group:</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Able to speak English, Afrikaans or Xhosa;

          -  Requesting and eligible for abortion according to standard practice at the hospital;

          -  Gestational age 13-20 weeks verified by ultrasound;

          -  Interested and eligible for the copper IUD as a post-abortion contraceptive method;

          -  Willingness to participate in the trial including follow-up;

          -  Able to provide a working phone &amp; telephone number to allow for contact;

          -  Willing and able to provide informed consent

          -  Staying within one hour travel time of GSH

        Exclusion Criteria:

          -  Active pelvic inflammatory disease, pelvic tuberculosis; severe thrombocytopenia;

          -  Positive N. Gonorrhea or C. Trachomatis that has not been adequately treated

          -  Copper allergy

          -  Hb &lt;10g/dL

          -  Uterine anomaly preventing placement of the IUD; cervical cancer or carcinoma in-situ,
             untreated high grade squamous intraepithelial lesions

          -  Hemorrhage; or ruptured uterus

          -  History of ectopic pregnancy

          -  Wilsons' disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Deborah Constant, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cape Town</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Groote Schuur Hospital</name>
      <address>
        <city>Cape Town</city>
        <state>Western Province</state>
        <zip>7925</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>South Africa</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 12, 2018</study_first_submitted>
  <study_first_submitted_qc>April 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2018</study_first_posted>
  <last_update_submitted>March 25, 2020</last_update_submitted>
  <last_update_submitted_qc>March 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cape Town</investigator_affiliation>
    <investigator_full_name>Deborah Constant, Dr</investigator_full_name>
    <investigator_title>Senior Researcher</investigator_title>
  </responsible_party>
  <keyword>second trimester medical abortion</keyword>
  <keyword>Immediate versus delayed insertion</keyword>
  <keyword>copper intrauterine device</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Copper</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Participant data will be made available from an institutional repository</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Data will become available following successful publication of findings - Expected date December 2020. No cut-off date</ipd_time_frame>
    <ipd_access_criteria>Through application to lead investigator</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

